蛋白酶抑制作用是否有其用武之地？文献综述
Is there a place for proteinase inhibition? A review of the literature.
作者信息
Lister G D
出版信息
Postgrad Med J. 1969 Aug;45(526):571-3. doi: 10.1136/pgmj.45.526.571.
Abstract
The evidence demonstrating excessive proteinase activity in states of shock is reviewed. The capacity of extrinsic inhibitors to control such activity is indicated and the literature showing the value of inhibitors in treating shock is summarized. Three principles to be observed in the use of exogenous inhibitors are proposed.
摘要
本文综述了休克状态下蛋白酶活性过高的相关证据。指出了外源性抑制剂控制此类活性的能力，并总结了表明抑制剂在治疗休克中价值的文献。提出了使用外源性抑制剂时应遵循的三个原则。
相似文献
1
Is there a place for proteinase inhibition? A review of the literature.蛋白酶抑制作用是否有其用武之地？文献综述
Postgrad Med J. 1969 Aug;45(526):571-3. doi: 10.1136/pgmj.45.526.571.
2
[Consumption coagulopathy].[消耗性凝血病]
Dtsch Med Wochenschr. 1970 Jun 5;95(23):1277-8. doi: 10.1055/s-0028-1108632.
3
[Coagulation analytic studies on the acute defibrination syndrome in the mother and child].
Monatsschr Kinderheilkd (1902). 1967 Apr;115(4):219-22.
4
Inhibition of proteinase in shock treatment.休克治疗中蛋白酶的抑制作用。
Acta Anaesthesiol Belg. 1974;25(1):143-66.
5
[Therapeutic use of natural proteinase inhibitors].[天然蛋白酶抑制剂的治疗用途]
Z Gesamte Inn Med. 1969 Nov 15;24(22):785-90.
6
Proteinases and proteinase inhibitors in experimental shock states.实验性休克状态下的蛋白酶和蛋白酶抑制剂
Ann N Y Acad Sci. 1968 Jun 28;146(2):491-516. doi: 10.1111/j.1749-6632.1968.tb20309.x.
7
The proteinases in shock.休克中的蛋白酶
Resuscitation. 1986 Sep;14(1-2):3-21. doi: 10.1016/0300-9572(86)90003-1.
8
Proteinase inhibitors in portasystemic shunts.门体分流中的蛋白酶抑制剂。
Ann N Y Acad Sci. 1968 Jun 28;146(2):777-87. doi: 10.1111/j.1749-6632.1968.tb20336.x.
9
[Proteinase inhibition in shock therapy. Colloquium September 7, 1973 at Cologne].[休克治疗中的蛋白酶抑制作用。1973年9月7日于科隆举行的学术讨论会]
Med Welt. 1973 Dec 7;24(49):1963-5.
10
Pathological fibrinolytic states and their treatment with epsilon aminocaproic acid (EACA).病理性纤溶状态及其用ε-氨基己酸（EACA）的治疗。
Br J Surg. 1966 Jan;53(1):26-9. doi: 10.1002/bjs.1800530105.
本文引用的文献
1
Formation of bradykinin in anaphylactic and peptone shock.过敏反应和蛋白胨性休克中缓激肽的形成。
Am J Physiol. 1950 Nov;163(2):283-9. doi: 10.1152/ajplegacy.1950.163.2.283.
2
3
PATHOLOGICAL FIBRINOLYSIS.病理性纤维蛋白溶解
Br Med Bull. 1964 Sep;20:240-6. doi: 10.1093/oxfordjournals.bmb.a070339.
4
EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.ε-氨基己酸及其他纤维蛋白溶解抑制剂
Br Med Bull. 1964 Sep;20:233-9. doi: 10.1093/oxfordjournals.bmb.a070338.
5
FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES.纤维蛋白溶解与生物活性多肽的形成
Br Med Bull. 1964 Sep;20:205-9. doi: 10.1093/oxfordjournals.bmb.a070332.
6
THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.抑肽酶对心血管手术相关纤溶活性的抑制作用
Surg Gynecol Obstet. 1964 Jul;119:71-4.
7
HEMORRHAGE DUE TO FIBRINOLYSIS OCCURRING WITH OPEN-HEART OPERATIONS.心脏直视手术中发生的纤维蛋白溶解所致出血
J Thorac Cardiovasc Surg. 1963 Nov;46:673-9.
8
EFFECT OF A TRYPSIN-INHIBITOR ON EXPERIMENTALLY INDUCED PANCREATITIS IN THE DOG.一种胰蛋白酶抑制剂对犬实验性诱导胰腺炎的作用。
Surgery. 1963 Dec;54:922-7.
9
INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.人纤维蛋白溶解和纤维蛋白原溶解的抑制作用：ε-氨基己酸与激肽释放酶抑制剂的比较
Thromb Diath Haemorrh. 1963 Nov 1;10:106-19.
10
Zotero 插件